Sunitinib Egis (Sunitinib Cyclamate)

Sunitinib Egis is an oral cancer treatment used to manage certain tumors. This prescription medication targets specific pathways in cancer cells. It belongs to the tyrosine kinase inhibitor class. Always follow healthcare provider guidance when using this drug.

Sunitinib Egis is prescribed for gastrointestinal stromal tumors and advanced kidney cancer. It may also be used for pancreatic neuroendocrine tumors under medical supervision. Patients often ask, 'What is Sunitinib used for?' to understand its role in treatment plans. This medication helps slow tumor growth by interfering with cancer cell signaling.

Common effects may include fatigue, digestive changes, or skin reactions. Some users notice mouth sores or changes in taste. These effects vary by individual and should be discussed with a healthcare professional. Most are temporary and manageable with supportive care.

Keep Sunitinib Egis in its original packaging away from moisture and heat. Store at room temperature and protect from light. Handle with care to avoid accidental exposure. Always use the prescribed dose and follow disposal guidelines for unused medication.

Sunitinib may interact with other drugs, including certain antibiotics or heart medications. Grapefruit products can affect how this medication works. Always inform your healthcare provider about all medications and supplements you are taking to prevent potential interactions.